IN2014DN10901A - - Google Patents

Info

Publication number
IN2014DN10901A
IN2014DN10901A IN10901DEN2014A IN2014DN10901A IN 2014DN10901 A IN2014DN10901 A IN 2014DN10901A IN 10901DEN2014 A IN10901DEN2014 A IN 10901DEN2014A IN 2014DN10901 A IN2014DN10901 A IN 2014DN10901A
Authority
IN
India
Application number
Other languages
English (en)
Inventor
Fernand Labrie
Original Assignee
Endorech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=49996456&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=IN2014DN10901(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Endorech Inc filed Critical Endorech Inc
Publication of IN2014DN10901A publication Critical patent/IN2014DN10901A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/56Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A61K31/568Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone
    • A61K31/5685Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol substituted in positions 10 and 13 by a chain having at least one carbon atom, e.g. androstanes, e.g. testosterone having an oxo group in position 17, e.g. androsterone
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0034Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/02Drugs for genital or sexual disorders; Contraceptives for disorders of the vagina
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • A61P15/12Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00Drugs for disorders of the endocrine system
    • A61P5/24Drugs for disorders of the endocrine system of the sex hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
IN10901DEN2014 2012-07-25 2014-12-19 IN2014DN10901A (ru)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261675717P 2012-07-25 2012-07-25
US13/942,977 US20140045806A1 (en) 2012-07-25 2013-07-16 Sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy
PCT/CA2013/000654 WO2014015416A1 (en) 2012-07-25 2013-07-19 Improvement of sexual arousal, sexual desire, orgasm and/or pleasure following intravaginal prasterone (dhea) administration in women not suffering or independently from dyspareunia or other symptoms of vulvo-vaginal atrophy

Publications (1)

Publication Number Publication Date
IN2014DN10901A true IN2014DN10901A (ru) 2015-09-11

Family

ID=49996456

Family Applications (1)

Application Number Title Priority Date Filing Date
IN10901DEN2014 IN2014DN10901A (ru) 2012-07-25 2014-12-19

Country Status (25)

Country Link
US (1) US20140045806A1 (ru)
EP (1) EP2877183B1 (ru)
JP (3) JP2015522625A (ru)
KR (4) KR102258122B1 (ru)
CN (2) CN111529536A (ru)
AR (1) AR091907A1 (ru)
BR (1) BR112015001479A2 (ru)
CA (2) CA2972491C (ru)
CL (1) CL2015000169A1 (ru)
DK (1) DK2877183T3 (ru)
EA (1) EA028263B1 (ru)
ES (1) ES2848215T3 (ru)
HK (1) HK1204983A1 (ru)
IL (1) IL236868B (ru)
IN (1) IN2014DN10901A (ru)
MA (1) MA37799B2 (ru)
MX (2) MX375078B (ru)
MY (1) MY183944A (ru)
NZ (2) NZ717808A (ru)
PH (1) PH12014502790A1 (ru)
SG (1) SG11201500228UA (ru)
TW (1) TWI693070B (ru)
UA (1) UA114517C2 (ru)
WO (1) WO2014015416A1 (ru)
ZA (1) ZA201409179B (ru)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020013304A1 (en) * 1997-10-28 2002-01-31 Wilson Leland F. As-needed administration of an androgenic agent to enhance female sexual desire and responsiveness
JP2005512995A (ja) * 2001-11-09 2005-05-12 ファイザー ヘルス アーベー 不安定又は過活動膀胱を治療するための抗ムスカリン剤及びエストロゲンアゴニスト
US20060252734A1 (en) * 2004-09-08 2006-11-09 Woodward John R Methods of female sexual enhancement
US8835413B2 (en) * 2004-10-20 2014-09-16 Endorecherche, Inc. Sex steroid precursors alone or in combination with a selective estrogen receptor modulator and/or with estrogens and/or a type 5 cGMP phosphodiesterase inhibitor for the prevention and treatment of vaginal dryness and sexual dysfunction in postmenopausal women
US8268806B2 (en) * 2007-08-10 2012-09-18 Endorecherche, Inc. Pharmaceutical compositions
WO2013012430A1 (en) * 2011-07-19 2013-01-24 Riepl Michael S Dhea bioadhesive controlled release gel

Also Published As

Publication number Publication date
CA2972491A1 (en) 2014-01-30
EP2877183A1 (en) 2015-06-03
KR102258122B1 (ko) 2021-05-28
IL236868A0 (en) 2015-03-31
HK1204983A1 (en) 2015-12-11
UA114517C2 (uk) 2017-06-26
IL236868B (en) 2020-09-30
JP6618887B2 (ja) 2019-12-11
AR091907A1 (es) 2015-03-11
SG11201500228UA (en) 2015-02-27
NZ717808A (en) 2017-08-25
AU2013296091B2 (en) 2016-01-07
ES2848215T3 (es) 2021-08-05
TW201408305A (zh) 2014-03-01
AU2013296091A1 (en) 2015-01-22
TWI693070B (zh) 2020-05-11
DK2877183T3 (da) 2021-03-08
MA37799B2 (fr) 2021-02-26
JP2019196404A (ja) 2019-11-14
BR112015001479A2 (pt) 2017-07-04
WO2014015416A9 (en) 2014-07-03
CA2879648C (en) 2017-10-31
PH12014502790B1 (en) 2015-02-09
EA201500165A1 (ru) 2015-07-30
KR20170095399A (ko) 2017-08-22
ZA201409179B (en) 2015-12-23
EA028263B1 (ru) 2017-10-31
EP2877183A4 (en) 2016-03-09
CN111529536A (zh) 2020-08-14
MX2015001064A (es) 2015-07-14
JP2017057211A (ja) 2017-03-23
MX2020009333A (es) 2020-10-08
CA2879648A1 (en) 2014-01-30
CL2015000169A1 (es) 2015-08-07
CN104540511A (zh) 2015-04-22
CA2972491C (en) 2020-12-29
JP6893960B2 (ja) 2021-06-23
EP2877183B1 (en) 2020-12-16
KR20200008055A (ko) 2020-01-22
MX375078B (es) 2025-03-06
JP2015522625A (ja) 2015-08-06
MY183944A (en) 2021-03-17
KR20210062746A (ko) 2021-05-31
NZ703168A (en) 2016-04-29
US20140045806A1 (en) 2014-02-13
KR20150033696A (ko) 2015-04-01
PH12014502790A1 (en) 2015-02-09
MA37799A1 (fr) 2016-08-31
WO2014015416A1 (en) 2014-01-30

Similar Documents

Publication Publication Date Title
BR112014017635A2 (ru)
BR112014017614A2 (ru)
BR112014017625A2 (ru)
BR112014017659A2 (ru)
BR112014017592A2 (ru)
BR112014017607A2 (ru)
BR112014017646A2 (ru)
BR112014017638A2 (ru)
BR112013027865A2 (ru)
BR112014017609A2 (ru)
BR112014017644A2 (ru)
BR112014017634A2 (ru)
BR112014017647A2 (ru)
BR112014017588A2 (ru)
BR112014013184A8 (ru)
BR112014017618A2 (ru)
BR112014017627A2 (ru)
BR112014017623A2 (ru)
BR112014017652A2 (ru)
BR112014017630A2 (ru)
BR112014017631A2 (ru)
BR112014017641A2 (ru)
BR112014017622A2 (ru)
BR112014017671A2 (ru)
BR112014017589A2 (ru)